1
LETTERS Should Initial Mastectomy Rates Increase? Jay Arthur Jensen, MD Santa Monica, CA Dr Feigelson and colleagues 1 should be commended for their interesting analysis, “Factors associated with the frequency of initial total mastectomy.” Although other studies 2,3 have documented an increase in mastectomy rates to between 35% and 45%, these authors reported a 16.7% rate of initial mastectomy when more strict exclusion criteria for study were met. They discussed vari- ables that might bear on a woman’s decision to choose mastectomy, including choice of surgeon and preopera- tive MRI scan, but there is one very important factor they did not examine: improved mastectomy and recon- struction have changed the patient’s choice. Early in my career, I argued that because of improved mastectomy and reconstructive techniques, the surgical option offered superior rates of local control and equiva- lent cosmetic outcomes for noninvasive 4 and invasive 5 breast cancer. With the further realization that routine removal of the uninvolved nipple during mastectomy did not confer a survival benefit to patients with early breast cancer, 6 many studies now demonstrate the improved esthetic outcomes of nipple-sparing mastec- tomy. 7-9 Reconstruction of a nipple-sparing mastectomy with a variety of techniques leaves the patient with an outcome that is cosmetically and oncologically equivalent to that with lumpectomy, but usually without the need for radiation therapy. Women facing mastectomy once were offered a simple choice: you can have breast preservation with lumpec- tomy and radiation therapy or you can be mutilated with a mastectomy. Which do you choose? But now the question is much different: we can leave your breast in place, remove the cancer, treat the surrounding tissue with radiation therapy, and monitor you carefully for recurrent cancer; or, we can remove your breast, spare your nipple, and leave you looking almost as good as you would look with lumpectomy but without the same risk of recurrent cancer in your breast. A woman’s choice has changed. The NIH Consensus Conference of 1991 acknowl- edged that lumpectomy and radiation therapy was an equivalent treatment to mastectomy for the majority of women with early breast cancer. But nipple-sparing mastectomy with immediate reconstruction changes the choice. It is now possible for a woman to enjoy the lower local recurrence rates of mastectomy with an equivalent cosmetic outcome to those of lumpectomy, with the addi- tional benefit that they are usually able to avoid radiation therapy. Therefore, as this choice becomes better under- stood by doctors and patients alike, we should expect to see a higher rate of mastectomy for the initial treatment of breast cancer. REFERENCES 1. Feigelson HS, James TA, Single RM, et al. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg 2013;216:966e975. 2. Habermann EB, Abbott A, Parsons HM, et al. Are mastectomy rates really increasing in the United States? J Clin Oncol 2010; 28:3437e3441. 3. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13 year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 2009;16:2682e2690. 4. Jensen JA, Handel N, Silverstein MJ. Glandular replacement therapy (GRT): An argument for a combined surgical approach in the treatment of non-invasive breast cancer. Breast J 1996;2: 121e123. 5. Jensen JA. Should improved mastectomy and reconstruction alter the primary management of breast cancer? Plast Recon- struct Surg 1999;103:1308e1310. 6. Jensen JA. When can the nipple-areola complex safely be spared during mastectomy? Plast Reconstruct Surg 2002;109: 805e807. 7. Benediktsson KP, Perbeck L. Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate recon- struction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol 2008;34:143e148. 8. Caruso F, Ferrara M, Castiglione G, et al. Nipple sparing subcutaneous mastectomy: sixty-six months follow-up. Eur J Surg Oncol 2006;32:937e940. 9. Gerber B, Krause A, Dieterich M, et al. The oncological safety of skin sparing mastectomy with conservation of the nipple- areolar complex and autologous reconstruction: an extended follow-up study. Ann Surg 2009;249:461e468. Disclosure Information: Nothing to disclose. Reply Adedayo A Onitilo, MD, MSCR, FACP Weston, WI 960 ª 2013 by the American College of Surgeons ISSN 1072-7515/13/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jamcollsurg.2013.07.397

Should Initial Mastectomy Rates Increase?

Embed Size (px)

Citation preview

Page 1: Should Initial Mastectomy Rates Increase?

ª 2013 by the American College of Surgeons

Published by Elsevier Inc.

LETTERS

Should Initial Mastectomy RatesIncrease?

Jay Arthur Jensen, MD

Santa Monica, CA

Dr Feigelson and colleagues1 should be commended fortheir interesting analysis, “Factors associated with thefrequency of initial total mastectomy.” Although otherstudies2,3 have documented an increase in mastectomyrates to between 35% and 45%, these authors reporteda 16.7% rate of initial mastectomy when more strictexclusion criteria for study were met. They discussed vari-ables that might bear on a woman’s decision to choosemastectomy, including choice of surgeon and preopera-tive MRI scan, but there is one very important factorthey did not examine: improved mastectomy and recon-struction have changed the patient’s choice.Early in my career, I argued that because of improved

mastectomy and reconstructive techniques, the surgicaloption offered superior rates of local control and equiva-lent cosmetic outcomes for noninvasive4 and invasive5

breast cancer. With the further realization that routineremoval of the uninvolved nipple during mastectomydid not confer a survival benefit to patients with earlybreast cancer,6 many studies now demonstrate theimproved esthetic outcomes of nipple-sparing mastec-tomy.7-9 Reconstruction of a nipple-sparing mastectomywith a variety of techniques leaves the patient with anoutcome that is cosmetically and oncologically equivalentto that with lumpectomy, but usually without the needfor radiation therapy.Women facing mastectomy once were offered a simple

choice: you can have breast preservation with lumpec-tomy and radiation therapy or you can be mutilatedwith a mastectomy. Which do you choose? But nowthe question is much different: we can leave your breastin place, remove the cancer, treat the surrounding tissuewith radiation therapy, and monitor you carefully forrecurrent cancer; or, we can remove your breast, spareyour nipple, and leave you looking almost as good asyou would look with lumpectomy but without the samerisk of recurrent cancer in your breast. A woman’s choicehas changed.The NIH Consensus Conference of 1991 acknowl-

edged that lumpectomy and radiation therapy was anequivalent treatment to mastectomy for the majority of

960

women with early breast cancer. But nipple-sparingmastectomy with immediate reconstruction changes thechoice. It is now possible for a woman to enjoy the lowerlocal recurrence rates of mastectomy with an equivalentcosmetic outcome to those of lumpectomy, with the addi-tional benefit that they are usually able to avoid radiationtherapy. Therefore, as this choice becomes better under-stood by doctors and patients alike, we should expect tosee a higher rate of mastectomy for the initial treatmentof breast cancer.

REFERENCES

1. Feigelson HS, James TA, Single RM, et al. Factors associatedwith the frequency of initial total mastectomy: results ofa multi-institutional study. J Am Coll Surg 2013;216:966e975.

2. Habermann EB, Abbott A, Parsons HM, et al. Are mastectomyrates really increasing in the United States? J Clin Oncol 2010;28:3437e3441.

3. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies onthe rise? A 13 year trend analysis of the selection of mastectomyversus breast conservation therapy in 5865 patients. Ann SurgOncol 2009;16:2682e2690.

4. Jensen JA, Handel N, Silverstein MJ. Glandular replacementtherapy (GRT): An argument for a combined surgical approachin the treatment of non-invasive breast cancer. Breast J 1996;2:121e123.

5. Jensen JA. Should improved mastectomy and reconstructionalter the primary management of breast cancer? Plast Recon-struct Surg 1999;103:1308e1310.

6. Jensen JA. When can the nipple-areola complex safely be sparedduring mastectomy? Plast Reconstruct Surg 2002;109:805e807.

7. Benediktsson KP, Perbeck L. Survival in breast cancer afternipple-sparing subcutaneous mastectomy and immediate recon-struction with implants: a prospective trial with 13 years medianfollow-up in 216 patients. Eur J Surg Oncol 2008;34:143e148.

8. Caruso F, Ferrara M, Castiglione G, et al. Nipple sparingsubcutaneous mastectomy: sixty-six months follow-up. Eur JSurg Oncol 2006;32:937e940.

9. Gerber B, Krause A, Dieterich M, et al. The oncological safetyof skin sparing mastectomy with conservation of the nipple-areolar complex and autologous reconstruction: an extendedfollow-up study. Ann Surg 2009;249:461e468.

Disclosure Information: Nothing to disclose.

Reply

Adedayo A Onitilo, MD, MSCR, FACP

Weston, WI

ISSN 1072-7515/13/$36.00

http://dx.doi.org/10.1016/j.jamcollsurg.2013.07.397